Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Management of heart failure in the new era

the role of scores

Mantegazza, Valentina; Badagliacca, Roberto; Nodari, Savina; Parati, Gianfranco; Lombardi, Carolina; Di Somma, Salvatore; Carluccio, Erberto; Dini, Frank Lloyd; Correale, Michele; Magrì, Damiano; Agostoni, Piergiuseppe on behalf of the “Insufficienza del cuore destro e sinistro group, a research group of the Italian Society of Cardiology

Journal of Cardiovascular Medicine: August 2016 - Volume 17 - Issue 8 - p 569–580
doi: 10.2459/JCM.0000000000000152
Reviews
Buy

Aims Heart failure is a widespread syndrome involving several organs, still characterized by high mortality and morbidity, and whose clinical course is heterogeneous and hardly predictable.

In this scenario, the assessment of heart failure prognosis represents a fundamental step in clinical practice. A single parameter is always unable to provide a very precise prognosis. Therefore, risk scores based on multiple parameters have been introduced, but their clinical utility is still modest.

Methods In this review, we evaluated several prognostic models for acute, right, chronic, and end-stage heart failure based on multiple parameters. In particular, for chronic heart failure we considered risk scores essentially based on clinical evaluation, comorbidities analysis, baroreflex sensitivity, heart rate variability, sleep disorders, laboratory tests, echocardiographic imaging, and cardiopulmonary exercise test parameters.

Results What is at present established is that a single parameter is not sufficient for an accurate prediction of prognosis in heart failure because of the complex nature of the disease. However, none of the scoring systems available is widely used, being in some cases complex, not user-friendly, or based on expensive or not easily available parameters.

Conclusion We believe that multiparametric scores for risk assessment in heart failure are promising but their widespread use needs to be experienced.

aCentro Cardiologico Monzino, IRCCS, Milano

bPulmonary Hypertension Unit, Department of Cardiovascular and Respiratory Disease, “Sapienza” University of Rome, Roma

cSpedali Civili Hospital of Brescia, Universityof Brescia, Brescia

dDepartment of Health Science, University of Milano Bicocca & Department of Cardiology, S. Luca Hospital, IstitutoAuxologicoItaliano

eSleep Disorders Center, Department of Cardiology, S. Luca Hospital, IstitutoAuxologicoItaliano, Milano

fDepartment of Medical Sciences and Translational Medicine, “Sapienza” University of Rome, Sant’Andrea Hospital, Roma

gDivision of Cardiology, University of Perugia, Perugia

hCardiac Thoracic and Vascular Department, University of Pisa, Pisa

iDepartment of Cardiology, University of Foggia, “OspedaliRiuniti” OO. RR, Foggia

jDepartment of Clinical and Molecular Medicine, “Sapienza” University of Rome, Roma

kDepartment of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milano, Italy

Correspondence to Piergiuseppe Agostoni, MD, PhD, Centro Cardiologico Monzino, IRCCS, Via Parea 4, 20138 Milan, ItalyTel: +39 02 58002586; e-mail: piergiuseppe.agostoni@unimi.it

Received 18 February, 2014

Revised 22 April, 2014

Accepted 30 April, 2014

© 2016 Italian Federation of Cardiology. All rights reserved.